# ClinicalTrials.gov record NCT06914154

> PeptideScanner retained ClinicalTrials.gov record NCT06914154 at 2026-07-30T16:25:18.014Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06914154-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06914154-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06914154-tirzepatide-v1.json
- Content SHA-256: `68f0604792c35524cb3ecf631814ea900edd51378246caa5f615b9b77a4ca1bb`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06914154 ([`ctg-observation-nct06914154-2026-01-30-46144a9bc44a`](#source-ctg-observation-nct06914154-2026-01-30-46144a9bc44a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06914154 at 2026-07-30T16:25:18.014Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06914154-2026-01-30-46144a9bc44a`](#source-ctg-observation-nct06914154-2026-01-30-46144a9bc44a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06914154 at 2026-07-30T16:25:18.014Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06914154-2026-01-30-46144a9bc44a`](#source-ctg-observation-nct06914154-2026-01-30-46144a9bc44a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06914154-2026-01-30-46144a9bc44a`](#source-ctg-observation-nct06914154-2026-01-30-46144a9bc44a))

## Sources

<a id="source-ctg-observation-nct06914154-2026-01-30-46144a9bc44a"></a>
- **ClinicalTrials.gov record NCT06914154 · retained source version 2026-01-30:46144a9bc44a51d6db183f182b4e407bedaf662c8e5f503252e3427f6552c161** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06914154) (`ctg-observation-nct06914154-2026-01-30-46144a9bc44a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06914154." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06914154-tirzepatide-v1.json SHA-256: 68f0604792c35524cb3ecf631814ea900edd51378246caa5f615b9b77a4ca1bb.